Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sagopilone

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Sagopilone?

Sagopilone is an investigational drug.

There have been 13 clinical trials for Sagopilone. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2005.

The most common disease conditions in clinical trials are Lung Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Bayer, Breast Cancer Research Foundation, and European Organisation for Research and Treatment of Cancer - EORTC.

Recent Clinical Trials for Sagopilone
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)BayerPhase 2
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesBayerPhase 2
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesBreast Cancer Research FoundationPhase 2

See all Sagopilone clinical trials

Clinical Trial Summary for Sagopilone

Top disease conditions for Sagopilone
Top clinical trial sponsors for Sagopilone

See all Sagopilone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.